Cyclacel Pharma (CYCC) Misses Q4 EPS by 33c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.33).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank monitors UK auto sales as Chinese exports grow
- LivePerson extends special meeting deadline for SoundHound AI merger vote
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
